Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Nevro Community
NYSE:NVRO Community
1
Narratives
written by author
0
Comments
on narratives written by author
0
Fair Values set
on narratives written by author
Create a narrative
Nevro
Popular
Undervalued
Overvalued
Community Investing Ideas
Nevro
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Restructuring And AI Trials Will Advance Spinal Cord Stimulation
Key Takeaways Strategic expense management and resource reallocation could enhance profitability and revenue, particularly through improved net margins and increased U.S. market activity. Innovative AI technology and regulatory approvals aim to expand market penetration and international reach, potentially boosting revenue and competitive positioning.
View narrative
US$6.53
FV
10.6% undervalued
intrinsic discount
3.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 1 month ago
author updated this narrative
Your Valuation for
NVRO
NVRO
Nevro
Your Fair Value
US$
Current Price
US$5.84
74.2% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-131m
487m
2015
2018
2021
2024
2025
2027
2030
Revenue US$487.1m
Earnings US$71.1m
Advanced
Set Fair Value